ArticleAmerican journal of respiratory and critical care medicine2020
Reply to Decroo
Kelly E Dooley, Sachiko Miyahara, Florian von Groote-Bidlingmaier, Xin Sun, Richard Hafner, Susan L Rosenkranz, Elisa H Ignatius, Eric L Nuermberger, Laura Moran, Kathleen Donahue and 3 more
Abstract readLetterComment
In one paragraphArticle in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
13 authors.
Sachiko MiyaharaHarvard T. H. Chan School of Public HealthBoston, Massachusetts.
Florian von Groote-BidlingmaierTASK Applied Science Cape Town, South Africa.
Xin SunHarvard T. H. Chan School of Public HealthBoston, Massachusetts.
Richard HafnerNational Institute of Allergy and Infectious DiseasesBethesda, Maryland.
Susan L RosenkranzHarvard T. H. Chan School of Public HealthBoston, Massachusetts.
Elisa H IgnatiusJohns Hopkins University School of MedicineBaltimore, Maryland.
Eric L NuermbergerJohns Hopkins University School of MedicineBaltimore, Maryland.
Laura MoranSocial & Scientific Systems, Inc.Silver Spring, Marylandand.
Kathleen DonahueFrontier Science and Technology Research FoundationAmherst, New York.
Susan SwindellsUniversity of Nebraska Medical CenterOmaha, Nebraska.
Naadira VankerTASK Applied Science Cape Town, South Africa.
Andreas H DiaconTASK Applied Science Cape Town, South Africa.
Funding
Clinical Pharmacology Training ProgramT32GM066691 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Matthew Michael Ippolito · 2003 to 2026
$6.4MMentoring Investigators in HIV and Tuberculosis Therapeutics ResearchK24AI150349 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOOLEY, KELLY E. · 2020 to 2025
$789kNIAID NIH HHS K24 AI150349NIGMS NIH HHS T32 GM066691
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
TuberculosisTuberculosis, Multidrug-ResistantHumansIsoniazidPyrazinamideRifampinIsoniazidPyrazinamideRifampin
Identifiers
PMID32130866
PMCPMC7301745
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390